Finding:

1. close

   Antibody

   The only antibody capable of crossing the placenta to give passive immunity to fetus. | ... "First-line Herceptin monotherapy in metastatic breast cancer".
2. close

   Monoclonal antibody therapy

   Chimeric and humanized antibodies have generally replaced murine antibodies in modern therapeutic antibody applications. ... Br J Cancer 2002; 87: 600-607.
3. close

   Cancer immunotherapy

   Cancer immunotherapy is the use of the immune system to reject cancer. ... | Antibody | Brand name | Approval date | Type | Target | Approved treatment(s) |
4. close

   Cancer

   Monoclonal antibody therapy is another strategy in which the therapeutic agent is an antibody which specifically binds to a protein on the surface of the cancer cells.
5. close

   Monoclonal antibodies

   Depending on how big a part of the mouse antibody is used, one talks about chimeric antibodies or humanized antibodies. ... "-tumu-" (cancer immunotherapy)
6. close

   Breast cancer

   Psychological aspects of diagnosis and treatment ... Breast cancer (Infiltrating ductal carcinoma of the breast) assayed with anti HER-2 (ErbB2) antibody
7. close

   Nimotuzumab

   Nimotuzumab is a humanized monoclonal antibody used to treat cancer.
8. close

   Catumaxomab

   Catumaxomab (brand name Removab) is a rat-murine hybrid monoclonal antibody which is used to treat some cancers such as platinum-refractory ovarian cancer, malignant ascites, and gastric cancer.
9. close

   Breast cancer treatment

   Typical hormonal treatments include: ... "Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2".
10. close

    Tucotuzumab celmoleukin

    Tucotuzumab celmoleukin is a humanized monoclonal antibody used to treat cancer.

Explore the following pages on Powerset:

• Antibody,
• Monoclonal antibody therapy,
• Cancer immunotherapy,
• Cancer,
• Monoclonal antibodies,
• Breast cancer,
• Nimotuzumab,
• Catumaxomab,
• Breast cancer treatment,
• Tucotuzumab celmoleukin